Steadview Capital makes partial exit from bulk drugs firm

By Bruhadeeswaran R

  • 01 Mar 2021
Premium
Credit: VCCircle

Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of the buoyant stock market valuations with the latest being one from a two-year-old investment in an active pharmaceutical ingredients (API) maker.  Steadview Capital, along with its affiliates, has sold about half a million shares through ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.